Cargando…
NIR‐II Excitation Phototheranostic Platform for Synergistic Photothermal Therapy/Chemotherapy/Chemodynamic Therapy of Breast Cancer Bone Metastases
To improve bone metastases treatment efficacy, current strategies are focused on the integration of chemotherapy with phototheranostic. However, the success of phototheranostic approaches is hampered by the limited tissue penetration depth of near‐infrared‐I (NIR‐I) light (700–900 nm). In this study...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685450/ https://www.ncbi.nlm.nih.gov/pubmed/36216756 http://dx.doi.org/10.1002/advs.202204718 |
_version_ | 1784835508370669568 |
---|---|
author | Sun, Pengfei Qu, Fan Zhang, Chi Cheng, Pengfei Li, Xiangyu Shen, Qingming Li, Daifeng Fan, Quli |
author_facet | Sun, Pengfei Qu, Fan Zhang, Chi Cheng, Pengfei Li, Xiangyu Shen, Qingming Li, Daifeng Fan, Quli |
author_sort | Sun, Pengfei |
collection | PubMed |
description | To improve bone metastases treatment efficacy, current strategies are focused on the integration of chemotherapy with phototheranostic. However, the success of phototheranostic approaches is hampered by the limited tissue penetration depth of near‐infrared‐I (NIR‐I) light (700–900 nm). In this study, a NIR‐II (1000–1700 nm) excitation phototheranostic (BTZ/Fe(2+)@BTF/ALD) is presented for NIR‐II fluorescence imaging and NIR‐II photoacoustic imaging‐guided NIR‐II photothermal therapy (PTT), chemotherapy, and chemodynamic therapy (CDT) of breast cancer bone metastases. This phototheranostic is developed by integrating a dopamine‐modified NIR‐II absorbing donor–acceptor–donor small molecule (BBT‐FT‐DA), the boronate anticancer drug bortezomib (BTZ), and Fe(2+) ions, as CDT catalysts, into an amphiphilic PEGylated phospholipid modified with the bone‐targeting ligand alendronate. In acidic and hydrogen peroxide (H(2)O(2)) over expression tumor microenvironment, the boronate–catechol linkage is cleaved and BTZ and Fe(2+) ions are released to initiate the Fenton reaction, that is, chemotherapy and CDT, respectively, are initialized. It is confirmed using the murine 4T1 bone metastasis model that BTZ/Fe(2+)@BTF/ALD significantly suppresses the progression of tumor cells in the bone tissue via a synergistic NIR‐II PTT/chemotherapy/CDT effect. Overall, this work provides fresh insights to guide the development of NIR‐II phototheranostics for breast cancer bone metastases. |
format | Online Article Text |
id | pubmed-9685450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96854502022-11-25 NIR‐II Excitation Phototheranostic Platform for Synergistic Photothermal Therapy/Chemotherapy/Chemodynamic Therapy of Breast Cancer Bone Metastases Sun, Pengfei Qu, Fan Zhang, Chi Cheng, Pengfei Li, Xiangyu Shen, Qingming Li, Daifeng Fan, Quli Adv Sci (Weinh) Research Articles To improve bone metastases treatment efficacy, current strategies are focused on the integration of chemotherapy with phototheranostic. However, the success of phototheranostic approaches is hampered by the limited tissue penetration depth of near‐infrared‐I (NIR‐I) light (700–900 nm). In this study, a NIR‐II (1000–1700 nm) excitation phototheranostic (BTZ/Fe(2+)@BTF/ALD) is presented for NIR‐II fluorescence imaging and NIR‐II photoacoustic imaging‐guided NIR‐II photothermal therapy (PTT), chemotherapy, and chemodynamic therapy (CDT) of breast cancer bone metastases. This phototheranostic is developed by integrating a dopamine‐modified NIR‐II absorbing donor–acceptor–donor small molecule (BBT‐FT‐DA), the boronate anticancer drug bortezomib (BTZ), and Fe(2+) ions, as CDT catalysts, into an amphiphilic PEGylated phospholipid modified with the bone‐targeting ligand alendronate. In acidic and hydrogen peroxide (H(2)O(2)) over expression tumor microenvironment, the boronate–catechol linkage is cleaved and BTZ and Fe(2+) ions are released to initiate the Fenton reaction, that is, chemotherapy and CDT, respectively, are initialized. It is confirmed using the murine 4T1 bone metastasis model that BTZ/Fe(2+)@BTF/ALD significantly suppresses the progression of tumor cells in the bone tissue via a synergistic NIR‐II PTT/chemotherapy/CDT effect. Overall, this work provides fresh insights to guide the development of NIR‐II phototheranostics for breast cancer bone metastases. John Wiley and Sons Inc. 2022-10-10 /pmc/articles/PMC9685450/ /pubmed/36216756 http://dx.doi.org/10.1002/advs.202204718 Text en © 2022 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Sun, Pengfei Qu, Fan Zhang, Chi Cheng, Pengfei Li, Xiangyu Shen, Qingming Li, Daifeng Fan, Quli NIR‐II Excitation Phototheranostic Platform for Synergistic Photothermal Therapy/Chemotherapy/Chemodynamic Therapy of Breast Cancer Bone Metastases |
title | NIR‐II Excitation Phototheranostic Platform for Synergistic Photothermal Therapy/Chemotherapy/Chemodynamic Therapy of Breast Cancer Bone Metastases |
title_full | NIR‐II Excitation Phototheranostic Platform for Synergistic Photothermal Therapy/Chemotherapy/Chemodynamic Therapy of Breast Cancer Bone Metastases |
title_fullStr | NIR‐II Excitation Phototheranostic Platform for Synergistic Photothermal Therapy/Chemotherapy/Chemodynamic Therapy of Breast Cancer Bone Metastases |
title_full_unstemmed | NIR‐II Excitation Phototheranostic Platform for Synergistic Photothermal Therapy/Chemotherapy/Chemodynamic Therapy of Breast Cancer Bone Metastases |
title_short | NIR‐II Excitation Phototheranostic Platform for Synergistic Photothermal Therapy/Chemotherapy/Chemodynamic Therapy of Breast Cancer Bone Metastases |
title_sort | nir‐ii excitation phototheranostic platform for synergistic photothermal therapy/chemotherapy/chemodynamic therapy of breast cancer bone metastases |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685450/ https://www.ncbi.nlm.nih.gov/pubmed/36216756 http://dx.doi.org/10.1002/advs.202204718 |
work_keys_str_mv | AT sunpengfei niriiexcitationphototheranosticplatformforsynergisticphotothermaltherapychemotherapychemodynamictherapyofbreastcancerbonemetastases AT qufan niriiexcitationphototheranosticplatformforsynergisticphotothermaltherapychemotherapychemodynamictherapyofbreastcancerbonemetastases AT zhangchi niriiexcitationphototheranosticplatformforsynergisticphotothermaltherapychemotherapychemodynamictherapyofbreastcancerbonemetastases AT chengpengfei niriiexcitationphototheranosticplatformforsynergisticphotothermaltherapychemotherapychemodynamictherapyofbreastcancerbonemetastases AT lixiangyu niriiexcitationphototheranosticplatformforsynergisticphotothermaltherapychemotherapychemodynamictherapyofbreastcancerbonemetastases AT shenqingming niriiexcitationphototheranosticplatformforsynergisticphotothermaltherapychemotherapychemodynamictherapyofbreastcancerbonemetastases AT lidaifeng niriiexcitationphototheranosticplatformforsynergisticphotothermaltherapychemotherapychemodynamictherapyofbreastcancerbonemetastases AT fanquli niriiexcitationphototheranosticplatformforsynergisticphotothermaltherapychemotherapychemodynamictherapyofbreastcancerbonemetastases |